MENU
+Compare
VCYT
Stock ticker: NASDAQ
AS OF
Aug 27, 03:19 PM (EDT)
Price
$28.86
Change
-$0.21 (-0.72%)
Capitalization
2.29B

VCYT Veracyte Forecast, Technical & Fundamental Analysis

Veracyte Inc is a genomic diagnostics company... Show more

Industry: #Biotechnology
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VCYT with price predictions
Aug 26, 2025

VCYT in upward trend: price rose above 50-day moving average on August 07, 2025

VCYT moved above its 50-day moving average on August 07, 2025 date and that indicates a change from a downward trend to an upward trend. In of 50 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 07, 2025. You may want to consider a long position or call options on VCYT as a result. In of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VCYT just turned positive on August 04, 2025. Looking at past instances where VCYT's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for VCYT crossed bullishly above the 50-day moving average on August 13, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VCYT advanced for three days, in of 293 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 142 cases where VCYT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for VCYT moved out of overbought territory on August 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where VCYT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VCYT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VCYT broke above its upper Bollinger Band on August 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VCYT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.873) is normal, around the industry mean (10.070). P/E Ratio (85.500) is within average values for comparable stocks, (137.190). VCYT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.808). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (4.843) is also within normal values, averaging (8.878).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VCYT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VCYT is expected to report earnings to fall 27.34% to 31 cents per share on November 11

Veracyte VCYT Stock Earnings Reports
Q3'25
Est.
$0.32
Q2'25
Beat
by $0.33
Q1'25
Beat
by $0.29
Q4'24
Beat
by $0.26
Q3'24
Beat
by $0.30
The last earnings report on August 06 showed earnings per share of 43 cents, beating the estimate of 10 cents. With 252.43K shares outstanding, the current market capitalization sits at 2.29B.
A.I. Advisor
published General Information

General Information

a company that discovers, develops and commercializes molecular diagnostic solutions

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
6000 Shoreline Court
Phone
+1 650 243-6300
Employees
815
Web
https://www.veracyte.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZESX12.50N/A
N/A
Lazard International Equity Select Open
HLMSX19.53N/A
N/A
Harding Loevner Intl Small Coms Inv
OTCGX22.96N/A
N/A
MFS Mid Cap Growth R1
TEMGX10.14N/A
N/A
Templeton Global Smaller Comp A
PGDRX11.97N/A
N/A
Principal Diversified Real Asset R3

VCYT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been closely correlated with NTLA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if VCYT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
-1.62%
NTLA - VCYT
69%
Closely correlated
-0.18%
VCEL - VCYT
60%
Loosely correlated
+1.84%
AXON - VCYT
58%
Loosely correlated
+0.72%
DNA - VCYT
57%
Loosely correlated
+6.06%
ABCL - VCYT
55%
Loosely correlated
+3.31%
More